Indication intelligence, analysis and sector perception

The Biostage (BSTG) Chronicles: filed an S-1 preliminary offering prospectus by Newbridge Securities Corporation.

June 23, 2022

Very lucky, BSTG settled terminal death suit as Dr. Paolo Macchiarini was found criminally liable in Swedish court for causing felony bodily injury to a patient, he had fitted with one of the artificial windpipes. With a three (3) year-old IND and multiple, and more Private Placements (PPM) that have funded WHAT? Who or whom U.S. investors invest in this equity are backing the wrong horse or just putting lipstick on a pig? Where did it all start; with CEO and founder David Green "ensnaring and entangling" BSTG with a terminal death suit “supplying” Paolo Macchiarini; an Italian doctor who made headlines for pioneering windpipe surgery has gone on trial in Sweden, charged with aggravated assault for performing the experimental procedure.

Chinook Therapeutics (KDNY) public offering of 6,4 M shares priced at $14.00 raising $105 M

June 2, 2022

KDNY priced (5/24/22) its underwritten public offering of 6,428,572 shares of its common stock at a price to the public of $14.00 per share. On 6/2/22, KDNY is trading at +$0.66 to $16.29 after trading 5/24/22 at $15.11

RegMed Investors (RMi) - Q1/22 Cell and Gene Therapy Earnings Scorecard Results

June 2, 2022

A scorecard of earnings releases of covered companies - 32 of 35 - so far The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status". Added Mesoblast (MESO) - this week